for patient preoperative characteristics, laboratory data, and comorbidities. Although intraoperative blood loss was included as an independent risk factor in the univariate analysis, the multivariate analysis revealed that baseline albumin and lactate levels were significantly associated with postoperative pressure ulcers. Further studies are required to confirm the effect of albumin administration on the development of pressure ulcers using a randomized controlled design.
The current study has few limitations. The lack of obvious modifiable factors is the main limitation. Pressure ulcers should be preventable. But the question as to how albumin and lactate levels can be controlled to prevent pressure ulcers remains unanswered. In Korea, the insurance policy does not allow albumin administration if the albumin level exceeds 3.0 g/dl. Lactate is an end product of anaerobic metabolism and is elevated upon tissue hypoxia. Lactate can be a useful biomarker of pressure ulcers. However, typically, there is no action performed to reduce lactate levels in the perioperative period.
It is not too much to emphasize the importance of positioning and use of pressure reducing surfaces to reduce the risk of pressure ulcers. In addition to this management, we must focus on preoperative and intraoperative risk factors.
